Remote Patient Monitoring‑Enabled Automated Peritoneal Dialysis and Clinical Outcomes
Clinical Journal of the American Society of Nephrology · 2026
DOI: 10.2215/cjn.0000001112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Journal of the American Society of Nephrology, 2026. Verfasst von Mu-Chi Chung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. Hauptthemen laut MEDLINE: Peritoneal Dialysis, Remote Patient Monitoring, Kidney Failure, Chronic. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Key Points Remote patient monitoring–enabled automated peritoneal dialysis was associated with improved survival and technique survival compared with conventional automated peritoneal dialysis. Remote patient monitoring‑enabled automated peritoneal dialysis was associated with significantly fewer annual hospitalizations compared with conventional automated peritoneal dialysis. The association between remote patient monitoring–enabled automated peritoneal dialysis and reduced hemodialysis transfer was more pronounced in younger patients and icodextrin users.
Introduction
Remote patient monitoring of patients on automated peritoneal dialysis (APD) enables real-time access to treatment data and has the potential to improve clinical outcomes. However, large-scale, nationwide real-world evidence comparing RPM-enabled APD (RPM-APD) with conventional APD remains limited.
Methods
We conducted a nationwide retrospective cohort study using Taiwan's National Health Insurance Research Database between 2016 and 2023. Patients initiating APD in medical centers during 2016–2018 (conventional APD) were compared with those starting RPM-APD equipped with a remote monitoring device during 2020–2022. Baseline covariates were balanced using inverse probability of treatment weighting. The primary outcomes were all-cause death and hemodialysis transfer. Secondary outcomes included peritonitis, major adverse cardiac events, and hospitalization. Patients were followed until outcome occurrence, death, hemodialysis transfer, kidney transplantation, or the end of follow-up (December 31, 2019, for conventional APD and December 31, 2023, for RPM-APD).
Results
Among the 2477 patients (RPM-APD, n =1258; conventional APD, n =1219), the mean age was 53.6 years, 54.6% were male, and the mean follow-up duration was 2.0 years. After inverse probability of treatment weighting adjustment, the RPM-APD group was associated with lower risks of all-cause death (4.4 versus 5.3 events per 100 person-years; hazard ratio 0.82, 95% confidence interval [CI], 0.69 to 0.99) and hemodialysis transfer (12.7 versus 15.1 events per 100 person-years; subdistribution hazard ratio 0.86, 95% CI, 0.77 to 0.96). The risks of peritonitis and major adverse cardiac events were similar between groups, whereas patients receiving RPM-APD experienced significantly fewer annual hospitalizations (1.6 versus 2.1 times; rate ratio 0.70, 95% CI, 0.68 to 0.73).
Conclusions
In this Taiwan nationwide real-world cohort study with long-term follow-up, RPM-APD was associated with improved patient survival, reduced hemodialysis transfer, and fewer annual hospitalizations compared with conventional APD. These findings support a potential role for RPM-APD in contemporary peritoneal dialysis care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
- Division of Clinical Toxicology, Department of Medical Toxicology, Taichung Veterans General Hospital, Taichung, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Division of Nephrology, Department of Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
- Division of Nephrology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
- Medical Affairs, Vantive Healthcare Ltd., Taipei, Taiwan.
ORCID-Profile: Ben-Chung Cheng, Chih-Yu Yang, Chi-Jung Chung
Zitieren
APA
Chung, M. C., Yu, T. M., Cheng, B. C., Yang, C. Y., Chan, C. I., & Chung, C. J. (2026). Remote Patient Monitoring‑Enabled Automated Peritoneal Dialysis and Clinical Outcomes. Clinical Journal of the American Society of Nephrology. https://doi.org/10.2215/cjn.0000001112
Vancouver
Chung MC, Yu TM, Cheng BC, Yang CY, Chan CI, Chung CJ. Remote Patient Monitoring‑Enabled Automated Peritoneal Dialysis and Clinical Outcomes. Clinical Journal of the American Society of Nephrology. 2026. doi:10.2215/cjn.0000001112
BibTeX
@article{Chung2026,
author = {Chung, Mu-Chi and Yu, Tung-Min and Cheng, Ben-Chung and Yang, Chih-Yu and Chan, Chan Ip and Chung, Chi-Jung},
title = {Remote Patient Monitoring‑Enabled Automated Peritoneal Dialysis and Clinical Outcomes},
journal = {Clinical Journal of the American Society of Nephrology},
year = {2026},
doi = {10.2215/cjn.0000001112}
}
EUVIMED